Enhance-d: Improving Diabetes Self-Management with AI and Real-Time Data

Enhance-d: Improving Diabetes Self-Management with AI and Real-Time Data

Enhance-d: Improving Diabetes Self-Management with AI and Real-Time Data

Now Available: Manage Your Diabetes with Enhance-d, Supported by DCB

Enhance-d: Diabetes Self-Management

We’re excited to announce that Enhance-d is now available! This innovative app empowers people with diabetes to better understand and manage their health. With real-time diagnostics, AI-powered analytics, and intuitive visualizations, Enhance-d transforms complex diabetes data into clear, actionable insights. Whether you’re organizing your daily routine or optimizing performance as an athlete, Enhance-d provides the tools you need to manage your diabetes self-management.

Key Features Include:

  • Real-Time Monitoring: Stay updated with live glucose data
  • AI-Driven Insights: Get personalized recommendations tailored to your needs
  • Clear Visualizations: Easily understand the impact of nutrition, exercise and other factors
  • Custom Alerts: Stay proactive with timely notifications

Now available on iOS and Android, Enhance-d connects seamlessly with CGMs, insulin delivery devices, wearables, and lifestyle apps to give you a complete picture of your health.

Learn more about the project and our collaboration here: https://www.dcberne.com/en/project/enhance-d-enhanced-diabetes-self-management/

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

DCB Open Innovation Challenge 2024 featured in the Swiss D-Journal

DCB Open Innovation Challenge 2024 featured in the Swiss D-Journal

DCB Open Innovation Challenge 2024 featured in the Swiss D-Journal

Explore the innovative breakthroughs from the DCB Open Innovation Challenge, highlighting cutting-edge solutions in diabetes care – mentioned in the latest D-Journal issue.  

Dive into D-Journal!

We proudly present an in-depth feature on the DCB Open Innovation Challenge in the latest issue of the D-Journal!  

This year, we received over 100 exciting project submissions, all aimed at advancing diabetes care through innovative solutions. Six outstanding finalists showcased their groundbreaking projects at the DCB Start-Up Night, making it an event to remember! 

For more details, explore the latest below embedded edition of the D-Journal, where you’ll find in-depth insights into these inspiring projects. 

The full article is available in both German and French. 

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

DCB Open Innovation Challenge 2024: Meet our Top 6!

DCB Open Innovation Challenge 2024: Meet our Top 6!

DCB Open Innovation Challenge 2024: Meet our Top 6!

The DCB Innovation Challenge 2024 is entering its final round! Explore the six innovations which have been chosen to move on to the bootcamp and finale, after rigorous evaluation by our esteemed jury.

Jorge Bondia (ES): AMIC Health – A digital ecosystem to educate children with type 1 diabetes through safe experimentation with gamified diabetes simulators

“AMIC Health is a digital ecosystem for the healthcare professional to educate children with type 1 diabetes through safe experimentation with gamified diabetes simulators and quantify effectiveness.”

Christine Brännvall (SE) : Beep Insights – Calculating insulin resistance based on level of physical activity

“The Beep app feature uses lactate measurement to estimate insulin resistance in relation to physical activity, CGM data, food  intake and sleep. Beep has built the world’s first in-app lactate step testing feature where both the test and the results are easily managed with a lactate testing device and analysed for you, without the need of any administration.”

Frédérik Plourde (CH) : Neuria – Evidence-based Neurocognitive Digital Therapeutics to restore healthy consumption behaviors without awareness

“Neuria’s gamified solution offers an evidence-based neurocognitive digital therapeutic that restores healthy consumption behaviors without awareness. Tested in 500+ individuals, it leverages brain plasticity and reduces cravings by 20%, consumption by 25%, and weight by 2-3% after a 15-hour intervention.”

Sufyan Hussain (UK) : Innodose – Device to reduce incidence of lipohypertrophy in long-term insulin users

“INNODOSE gamifies the injection process to reduce the incidence of lipohypertrophy in insulin-treated diabetes – with a co-design informed innovation of a novel insulin pen and pen-adaptor, drawing on collaboration between academics, clinicians, practitioners, engineers and designers at King’s College London, and with a focus on co-production with the end users.”

Muhammad Mujeeb-U-Rahman (US): CGM+ – Unleashing the Power of Next-Gen Monitoring for Diabetes

“Integrated Medical Sensors (IMS) has developed the world’s smallest, first fully-integrated (single chip) and first multi-sensor minimally invasive CGM, taking diabetes monitoring to the next level. It can monitor glucose using multiple independent sensors on the same device. In addition, it measures physiological parameters (e.g., tissue temperature) using the same device. Moreover, it can also measure multiple analytes (e.g., glucose and ketones) using a single device.”

Yuta Matsuda (US) : Genomelink – Innovative DNA Testing: A New Horizon in Type 1 Diabetes Diagnosis

“Misdiagnosis between T1D and T2D is common due to a lack of accessible diagnostic methods. Our new DNA test offers a more accessible and accurate tool for diagnosis. Unlike the fluctuating antibody levels, genetic markers associated with T1D do not change over a person’s lifespan, providing a stable diagnostic criterion.”

We are looking forward to entering this next round of our Innovation Challenge: a one week bootcamp in the Swiss mountains and the grand finale on 3 October!

    Download the PDF Overview

    Sign up for our newsletter and stay up to date.

    * Pflichtfelder
    DSGVO *

    DCB Research AG

    Freiburgstrasse 3
    3010 Bern
    Switzerland

    DCB Open Innovation Challenge 2024: Meet our Top 20!

    DCB Open Innovation Challenge 2024: Meet our Top 20!

    DCB Open Innovation Challenge 2024: Meet our Top 20!

    The DCB Open Innovation Challenge 2024 is entering its next round! From all 100 submitted ideas, our evaluation committee has now selected the Top 20.

    Meet our Top 20!

    Following a meticulous evaluation of incredible 100 submissions for our Open Innovation Challenge, our team has selected the top 20 ideas to advance to the next phase.

    We are pleased to announce the innovative concepts that have successfully progressed. This year’s submissions have surpassed expectations, and we eagerly anticipate mentoring with these 20 outstanding innovators. Among them, 2 from the US and 4 from around the globe will later be chosen as finalists, earning the opportunity to participate in our bootcamp and competing for the win at our prestigious award ceremony.

    As we embark on this journey, we invite you to explore the detailed profiles of the top 20 innovators in the attached PDF. Let us collectively celebrate innovation and collaboration as we move forward!

    Downloads

    More recent news

    Sign up for our newsletter and stay up to date.

    * Pflichtfelder
    DSGVO *

    DCB Research AG

    Freiburgstrasse 3
    3010 Bern
    Switzerland

    The DCB Open Innovation Challenge is Back: Submit Your Idea Now!

    The DCB Open Innovation Challenge is Back: Submit Your Idea Now!

    The DCB Open Innovation Challenge is Back: Submit Your Idea Now!

    For the fourth time, the Diabetes Center Berne is launching the Open Innovation Challenge with the aim of specifically promoting innovative projects in the field of diabetes management on Swiss and international level. Participating innovtors benefit from professional expert feedback, and the six best projects receive access to a bootcamp. The finalists will receive prize money of up to USD 100,000 and further support from the DCB. The DCB Innovation Challenge is the world’s largest diabetes technology award with international appeal.

    Can Your Idea Change Diabetes Management?

    More than 537 million people worldwide live with diabetes, which means a constant challenge in everyday life for those affected. Technological innovations make an important contribution to making it easier to deal with diabetes – whether it is measuring glucose levels, planning the amount of insulin needed via an app or even using automated insulin delivery systems. But despite these enormous advances in diabetes technology, there is still a great, unmet need for innovative technical solutions. These should help to ease the challenge for users in everyday life and improve the lives of people with diabetes in the long term.

    The DCB Open Innovation Challenge was initiated in 2021 with the aim of closing these gaps in diabetes technology with translational research. The goal of the challenge is to identify unique solutions which can make life easier for people with diabetes. Whether you’re a researcher, healthcare professional, start-up founder, or someone living with diabetes, your ideas are invaluable to us. We’re seeking diverse perspectives and innovative solutions to enhance the quality of life for individuals with diabetes.

     

    What’s in it for you?

    After a first round and feedback from the expert jury, the top 20 will enter a mentoring program. Two US-based innovators and four innovators from the rest of the world will be invited to an individually tailored bootcamp in the picturesque Swiss alps and will then pitch their final ideas at the grand DCB Start-Up Night in Berne, Switzerland, on 3 October 2024. Additionally, all finalists have the opportunity to present their ideas at the Diabetes Technology Meeting in the US on 15–17 October 2024.​

    The winning project will be selected by an international expert jury and rewarded with USD 100,000 in funding and in-kind support – making the DCB Open Innovation Challenge the world’s largest diabetes technology award with international appeal. You will get access to a global network of experts from the field – all while your idea remains entirely yours.

    Don’t miss out on this unparalleled opportunity to turn your idea into reality. Submit your idea by April 30 at our innovation platform innovation.dcberne.com

    More recent news

    Sign up for our newsletter and stay up to date.

    * Pflichtfelder
    DSGVO *

    DCB Research AG

    Freiburgstrasse 3
    3010 Bern
    Switzerland

    Diabetes Center Berne and Diabetes Technology Society Collaborate for the 2024 DCB Open Innovation Challenge

    Diabetes Center Berne and Diabetes Technology Society Collaborate for the 2024 DCB Open Innovation Challenge

    Diabetes Center Berne and Diabetes Technology Society Collaborate for the 2024 DCB Open Innovation Challenge

    We are very excited to announce the launch of the 2024 DCB Open Innovation Challenge for 1 April 2024, this year in collaboration with the Diabetes Technology Society!

    Can Your Idea Change Diabetes Management Forever?

    We are excited to announce the collaboration of the Diabetes Center Berne and the Diabetes Technology Society for the 2024 DCB Open Innovation Challenge, launching on 1 April 2024.​

    The DCB Open Innovation Challenge was initiated in 2021 and is the largest innovation challenge in the field of diabetes technology. The goal of the challenge is to identify unique solutions which can make life easier for people with diabetes. Anyone with an idea can apply – whether researcher, healthcare professional, start-up or person living with diabetes. We want to hear from you!​

    In 2024, two US-based innovators and four innovators from the rest of the world will be selected to pitch their final ideas at the grand DCB Start-Up Night in Berne, Switzerland, on 3 October 2024. Additionally, all finalists have the opportunity to present their ideas at the Diabetes Technology Meeting in the US on 15–17 October 2024.​ ​

    Save the dates and seize the opportunity to watch your idea become reality: www.dcberne.com/en/innovation-challenge

    More recent news

    Sign up for our newsletter and stay up to date.

    * Pflichtfelder
    DSGVO *

    DCB Research AG

    Freiburgstrasse 3
    3010 Bern
    Switzerland